On 2025-05-08, Janux Therapeutics, Inc. (JANX) announced earnings per share of $-0.38 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.43.
The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-0.50 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.43 | $-0.38 |
| 2025-02-27 | 2024-12-31 | $-0.49 | $-0.36 |
| 2024-11-06 | 2024-09-30 | $-0.37 | $-0.51 |
| 2024-08-07 | 2024-06-30 | $-0.32 | $-0.11 |
| 2024-05-07 | 2024-03-31 | $-0.35 | $-0.30 |
| 2024-03-08 | 2023-12-31 | $-0.37 | $-0.25 |
| 2023-11-07 | 2023-09-30 | $-0.46 | $-0.25 |
| 2023-08-08 | 2023-06-30 | $-0.52 | $-0.42 |
| 2023-05-09 | 2023-03-31 | $-0.49 | $-0.42 |
| 2023-03-10 | 2022-12-31 | $-0.45 | $-0.39 |
| 2022-11-10 | 2022-09-30 | $-0.51 | $-0.40 |
| 2022-08-09 | 2022-06-30 | $-0.37 | $-0.41 |
| 2022-05-10 | 2022-03-31 | $-0.37 | $-0.32 |
| 2022-03-18 | 2021-12-31 | $-0.30 | $-0.33 |
| 2021-11-09 | 2021-09-30 | $-0.17 | $-0.26 |
| 2021-08-10 | 2021-06-30 | $-0.12 | $-0.62 |